Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

News & Analysis

China biotech company and industry news and analysis...

Week in Review: Ocumension Climbs to $2.5 Billion Market Cap after $184 Million Hong Kong IPO

Ocumension Stages $184 Million HK IPO; Climbs 152% on First Day

Germany's Merck Opens Shanghai Collaboration Center

Harbour BioMed Closes $103 Million Financing for Biologic Portfolio

Clover Bio Raises $66 Million from CEPI for Trimer-Tag COVID-19 Vaccine

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China